All data are as of 20 September 2017. All data are as of 20 September 2017. Table 4 ). In the top 10 best-cited papers published in the European Journal of Heart Failure, three are guidelines and four are big reviews. The next 10 best-cited papers contain no guidelines, but others are five reviews, one meta-analysis, and one trial design paper (Table 4) . If one does not consider biomarker papers on circulating levels of cardiac autoantibodies 129 or of microRNA 139 basic science-which we don't-then we need to conclude that not a single article of the top 50 cited papers in the European Journal of Heart Failure deals with basic science research. This may be considered a weakness of the journal, or simply a reality. The basic science community does not submit its best papers to this journal, which is considered to mostly serve a clinical readership.
We believe that the results of this short analysis are not surprising. They can make the working of the impact factor and the realities of publishing articles better understandable or even predictable. We believe that the European Journal of Heart Failure under the stewardship of Marco Metra is thriving, and we are most optimistic that the journal will grow further in the next few years in quality, readership, and reach, and likely also in impact factor. Vernay M, Olié V. National trends in rate of patients hospitalized for heart failure and heart failure mortality in
